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Abstract
IFN-c-mediated inducible nitric oxide synthase (iNOS) expression is critical for controlling chlamydial infection through
microbicidal nitric oxide (NO) production. Interleukin-17A (IL-17A), as a new proinflammatory cytokine, has been shown to
play a protective role in host defense against Chlamydia muridarum (Cm) infection. To define the related mechanism, we
investigated, in the present study, the effect of IL-17A on IFN-c induced iNOS expression and NO production during Cm
infection in vitro and in vivo. Our data showed that IL-17A significantly enhanced IFN-c-induced iNOS expression and NO
production and inhibited Cm growth in Cm-infected murine lung epithelial (TC-1) cells. The synergistic effect of IL-17A and
IFN-c on Chlamydia clearance from TC-1 cells correlated with iNOS induction. Since one of the main antimicrobial
mechanisms of activated macrophages is the release of NO, we also examined the inhibitory effect of IL-17A and IFN-c on
Cm growth in peritoneal macrophages. IL-17A (10 ng/ml) synergizes with IFN-c (200 U/ml) in macrophages to inhibit Cm
growth. This effect was largely reversed by aminoguanidine (AG), an iNOS inhibitor. Finally, neutralization of IL-17A in Cm
infected mice resulted in reduced iNOS expression in the lung and higher Cm growth. Taken together, the results indicate
that IL-17A and IFN-c play a synergistic role in inhibiting chlamydial lung infection, at least partially through enhancing iNOS
expression and NO production in epithelial cells and macrophages.
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Introduction
Chlamydia trachomatis, as an obligate intracellular bacterium,
causes a wide variety of human and animal diseases including
ocular, pulmonary, and genital infections. Strong Th1 responses
marked by IFN-c production are crucial for controlling chlamydial
infection [1]. IFN-c mediates antimicrobial action by activation of
phagocytes for rapid uptake and degradation of pathogenic
particles, and by inducing cellular enzymes, such as indoleamine
2, 3-dioxygenase (IDO), which cause tryptophan deprivation [2,3]
and inducible nitric oxide synthase (iNOS) which promote
microbicidal nitric oxide (NO) production [1,4]. It has been
reported that iNOS rather than IDO is important for chlamydial
control in mice [1,5]. IFN-c R
2/2 or iNOS
2/2 mice show higher
pulmonary levels of chlamydial mRNA in comparison with wild-
type (WT) mice after chlamydial infection [6,7]. IFN-c can also act
directly on epithelial cell to inhibit the intracellular growth of
Chlamydiae in vitro through inducing NO production [1]. However,
uncontrolled NO release has also been implicated in inflamma-
tion. Therefore, proper modulation of iNOS-mediated NO release
is important for therapeutic optimization of protective immunity
and prevention of detrimental effects of inflammation during
chlamydial infection [8,9].
Interleukin-17A(IL-17A) is mainly produced by activated CD4
+
T cells (Th17) and some other innate immune cell types such as
cdT cells and NK1.1
2 invariant NKT cells [10,11,12,13]. Some
data have proved that Th17/IL-17A is involved in host defense
against intracellular bacterial infections, such as, mycobaterial
infection through neutrophil induction and Th1 enhancement in
mice [10]. Our previous study also showed that IL-17A/Th17
played an important role in defense against Chlamydia lung
infection through modulating DC function and augmenting Th1
response [14]. Recently, IL-17A has gained increasing attention as
a mediator of iNOS expression in a variety of cell types, such as
human chondrocytes and murine osteoblasts, endothelial and beta
cells which are involved in pathogenesis of some autoimmune
diseases [15,16]. Our previous study has shown that IL-17A-
neutralized mice exhibited significantly higher chlamydial growth
in the lung than sham-treated control mice [14]. Considering the
importance of iNOS in controlling chlamydial infection, we
hypothesized that IL-17A is involved in inhibition of intracellular
Cm growth through enhancing iNOS expression and NO
production.
PLoS ONE | www.plosone.org 1 June 2012 | Volume 7 | Issue 6 | e39214In the present study, we first investigated the effect of IL-17A on
iNOS expression in murine pulmonary epithelial cell line TC-1
and macrophage cell line RAW264.7 and found up-regulation of
iNOS by IL-17A. Further experiments showed that IL-17A alone
or in synergy with IFN-c has a direct inhibitory effect on Cm
growth in the pulmonary epithelial cell and peritoneal macro-
phages of mice. Finally, through adding of AG (a potent inhibitor
of iNOS) into the system, we confirmed that the synergy of IL-17A
and IFN-c in inhibition of intracellular Cm growth is at least partly
mediated by up-regulation of iNOS expression and NO pro-
duction.
Materials and Methods
Culture of TC-1 and RAW264.7
The murine lung epithelial cell line TC-1 and macrophage cell
line RAW264.7 were obtained from American Type Culture
Collection (ATCC). TC-1 and RAW264.7 cells were grown in 24-
well plates at density of 3–5 million cells per well in RPMI 1640
medium with 10% FBS. Before treatment with cytokines, cells
were incubated in RPMI 1640 medium with low (0.5%) FBS
without penecilin/streptomycin overnight to starve cells for more
efficient taken up of cytokines by the cells. Cells were treated with
10 mg/ml mouse recombinant IL-17A (rmIL-17A) or 20 ng/ml
mouse recombinant IFN-c (rmIFN-c) (both were obtained from
PeproTech Inc.) in various combinations for 6 h. Endotoxin levels
in commercial rmIL-17A, rmIFN-c and rmTNF-a were less than
0.1 ng in 1 mg of the cytokine. Cells were harvested for iNOS
mRNA expression assay and iNOS activity assay, while the cell
culture supernatants were harvested for NO production detection.
Infection of TC-1 Cells
Chlamydia muridarum (Cm), a natural mouse chlamydial strain,
was propagated in Hep-2 cells (ATCC) as described previously
[17]. TC-1 cells were seeded into 24- and 12- well plates at
a density of 2–3610
5 cells/ml, and cultured for 24 h. Cell
monolayers were washed twice with phosphate buffered saline
(PBS) and infected with Cm diluted in RPMI 1640 medium. Plates
were placed at 37uCi n5 %C O 2 incubator for 2 h and the
extracellular bacteria were removed by washing with PBS.
Subsequently, cells were cultured in fresh RPMI-1640 containing
0.5% FBS, in the presence or absence of rmIL-17A and/or
rmIFN-c at the indicated concentrations. The cells from 24-well
plates were harvested for iNOS mRNA expression assay and
iNOS activity assay at 6 h, 24 h and 36 h after infection, and the
cell culture supernatants were harvested for NO production
detection. Measurement of chlamydial growth in the wells of
different combinations of cytokines was performed by staining of
chlamydial inclusion in the 12-well plates at 36 h after infection
using anti-chlamydial LPS mAb and was shown as inclusion
forming units (IFUs)/ml as described previously [14]. The effect of
rmIL-17A and rmIFN-c on the inhibition of Cm growth was
measured by inhibition rate as calculated below [1]:
Inhibition rate (%) = (mean IFUs/ml of control wells – mean
IFUs/ml of experimental wells)6100%/mean IFUs/ml of control
wells.
Infection of Macrophages with Cm in vitro
Peritoneal macrophages were collected from BALB/c mice
following thioglycollate (4%, 1.5 ml/mouse) injection as described
Figure 1. Effect of IL-17A and IFN-c on iNOS gene expression, iNOS activity and NO production in TC-1 cells. TC-1 cells were cultured
and treated with rmIL-17A (10 ng/ml) and/or rmIFN-c (20 ng/ml) for 6 h. Cells were harvested, RNA was isolated and the mRNA level of iNOS was
measured by RT-PCR. b-actin was used as an internal control. The representative gels were presented (A). The values of iNOS expression were
normalized to b-actin and expressed as the mean 6 SD of triplicate measurements (B). iNOS activity of cell lysates was detected by the
chromatometry method (C). NO concentration in cell culture supernatants was detected using NO nitrate reductase method (D). *P,0.05, **P,0.01.
doi:10.1371/journal.pone.0039214.g001
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cavity with 8 ml Hanks balanced salt solution (HBSS) 4 days after
thioglycollate injection, followed by centrifugation (210 g, 10 min)
of the lavage fluids. Following lysing red blood cells with 0.85%
NH4Cl, the peritoneal cells (mostly macrophages) were resus-
pended at 2610
6 cells/ml with 10% FBS RPMI-1640 medium
and were set into 96-well culture plates at 100 ml/well. Two hours
after incubation at 37uCi naC O 2 incubator, unattached cells
were washed away with HBSS. Fresh complete culture medium
(200 ml/well) was added into wells and the plates were further
incubated overnight at 37uC to form cell monolayers. The
macrophage monolayers were then inoculated with Cm for 2 h
followed by washing with HBSS. After that, fresh complete culture
medium with different concentrations of rmIFN-c (10 or 200 ng/
ml) and/or rmIL-17A (10 ng/ml or 100 ng/ml) were added to the
wells at 200 ml/well. In the specified experiments, aminoguanidin
(AG, Sigma) was added to the wells containing rmIFN-c and/or
rmIL-17A at a final concentration of 100 mM. Following 48 h
culture, chlamydial inclusions in the macrophage monolayers were
stained and the percentage inhibition was computed using the
same formula shown above.
Infection of Mice and Neutralization of Airway IL-17A
Female BALB/c mice, 6–8 week old, were kept in a specific
pathogen-free facility at the central animal care facility in Tianjin
Medical University with filtered air flow and autoclaved cage, food
and water. Mice were anesthetized and inoculated intranasally with
1610
3inclusion formingunits(IFUs) ofCmin40 mlfinalvolumeof
PBS. For neutralization of airway IL-17A, mice were intranasally
administeredwith10 mgofanti-mouseIL-17AmAb(R&D)in40 ml
of PBS at 2 h postinfection (p.i.), followed by subsequent adminis-
trationofthesamedoseofAbat48-hintervals.Infectedcontrolmice
were administered intranasally with isotype control (IgG2a)
antibody in the same schedule as anti-IL-17A delivery. Mice were
killed at day 7 after infection and the lungs were isolated for gene
Figure 2. Effect of IL-17A and IFN-c on iNOS gene expression,
iNOS activity and NO production at various times following Cm
infection. Cultured TC-1 cells were infected with Cm at MOI 2 and
treated with rmIL-17A (10 ng/ml) and/or rmIFN-c (20 ng/ml) at 2 h
post-infection. The cells were harvested at 6, 24 and 36 h after infection
and RNAs were isolated. The mRNA level of iNOS was measured by RT-
PCR (A). The values of iNOS expression were normalized to b-actin. The
results were presented as the mean 6 SD of triplicate measurements.
iNOS activity of cell lysate was detected by chromatometry method (B).
NO concentration in cell culture supernatants was detected using NO
nitrate reductase method (C). *P,0.05, **P,0.01, ***P,0.001.
doi:10.1371/journal.pone.0039214.g002
Figure 3. Inhibition of IL-17A and IFN-c on intracellular Cm
growth in TC-1 cell. TC-1 cell monolayers were infected with Cm and
treated with rmIL-17A (10 or 50 ng/ml) and/or rmIFN-c (20 ng/ml) at
2 h post-infection. Cm inclusions in the infected TC-1 cells at 36 h after
infection were stained with anti-chlamydial LPS mAb. Cm was
quantified as inclusion forming units (IFUs)/ml. The representative
pictures of Cm inclusions in different groups were shown (A). The
percentage of inhibition was calculated as described in the Materials
and Methods (B). iNOS activity of cell lysate was detected by
chromatometry method (C). The results were expressed as the mean
6 SD of triplicate measurements. *P,0.05, **P,0.01, ***P,0.001.
doi:10.1371/journal.pone.0039214.g003
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in this study were used in accordance with the guidelines issued by
the Chinese Council on Animal Care and animal experimental
protocol approved by the ethical committee of Tianjin Medical
University (Approval Number: TY10-101).
RT-PCR
Transcriptase-polymerase chain reaction (RT-PCR) was used to
assay iNOS mRNA expression. Total RNA was prepared using
a Rapid RNA Extraction Kit (Bioteke Corporation, China)
according to the manufacturer
’s protocol. Total RNA (1 mg) was
reverse-transcribed into cDNA which was then amplified using
specific primers for iNOS and b-actin. The PCR primers used in
this study were as follows: iNOS, 59-
CCCTTCCGAAGTTTCTGGCAGCAGCAGC-39(sense) and
59-GGCTGTCAGAGCCTCGTGGCTTTGG-39 (anti-sense) to
give a 445-bp product; b-actin, 59-ATGGATGACGA-
TATCGCT-39 (sense) and 59-ATGAGGTAGTCTGTCAGGT-
39(anti-sense) to give a 585-bp product. PCR conditions were as
follows: iNOS and b-actin: 94uC 10 min, followed by 30 cycles of
94uC for 50 s, 55uC for 45 s and 72uC for 45 s. PCR products
were electrophoresed on 1.5% agarose gel containing ethidium
bromide (0.0003%). The bands were visualized and photographed
using ultraviolet transillumination and were analysed for density
on Quantity One software and normalized against b-actin signal
from the same sample.
Detection of iNOS Activity in Cell Lysates
iNOS activity in cell lysates was detected using an Isoforms of
Nitric Oxide Synthase Assay Kit (Nanjing Jiancheng Bioengineer-
ing Institute, Nanjing, China) according to the manufacturer’s
protocol. Briefly, cell lysates were prepared by sonicating the cells
in 0.5 ml of cold PBS and the protein concentrations were
determined. Then, the absorbance of differential samples in
530 nm was detected by a chromatometry method. The iNOS
activity was calculated according to the formula provided by the
manufacturer of the Kit.
Determination of NO Concentration in Cell Culture
Supernatants
NOconcentrationincell culturesupernatants wasdetectedusing
aNOnitrate reductaseassaykit(NanjingJianchengBioengineering
Institute,Nanjing,China)accordingtothemanufacturer’sprotocol.
NO concentration was calculated according to the following
formula: NO (mmol/L) = standard concentration(100 mmol/
L)6Dilution factory of sample6(OD of NO measuring tube–OD
of blank tube )/(OD of Standard – OD of Blank).
Statistical Analysis
Statistical analysis was performed using SPSS 12.0 version
software. For comparisons of more than groups, data were
subjected to one-way ANOVA followed by the Student-Newman-
Keuls multiple comparison test.
Results
IL-17A Synergizes with IFN-c for Enhancing iNOS
Expression and NO Production by TC-1 Cells in the
Absence of Infection
IFN-c-mediated antimicrobial action is mainly dependent on
inducing cellular enzymes, such as inducible nitric oxide synthase
(iNOS) to produce microbicidal NO [1,4]. We first tested the effect
of IL-17A and IFN-c on iNOS and NO production in uninfected
TC-1 cell, a murine lung epithelial cell line. The results showed
that IL-17A alone had no effect on iNOS and NO production, but
it significantly augmented IFN-c-induced enhancement of iNOS
mRNA expression (Fig. 1A and B), iNOS activity (Fig. 1C) and
NO production (Fig. 1D).
IL-17A Synergizes with IFN-c for Enhancing iNOS and NO
Production in Cm-Infected TC-1 Cells
We further evaluated the effects of IL-17A on iNOS mRNA
expression, iNOS activity, and NO production in Cm-infected TC-
1 cells. As shown in Fig. 2A, at 6 h after Cm infection, only the
wells with combined IL-17A and IFN-c stimulation showed
measurable iNOS mRNA expression, but not those with single
cytokine. At 24 h and 36 h after infection, the mRNA expression
of iNOS were measured in all groups but the expression in the
Figure 4. Effect of IL-17A and IFN-c on iNOS gene expression,
iNOS activity and NO production in RAW 264.7 cells. RAW 264.7
cells were cultured and treated with rmIL-17A (10 ng/ml) and/or rmIFN-
c (20 ng/ml) for 6 h. Cells were harvested, RNA was isolated and the
mRNA level of iNOS was measured by RT-PCR. b-actin was used as an
internal control. The representative gels were presented. The values of
iNOS expression were normalized to b-actin and expressed as the mean
6 SD of triplicate measurements (A). iNOS activity of cell lysates was
detected by chromatometry method (B). NO concentration in cell
culture supernatant was detected using NO nitrate reductase method
(C). *P,0.05, **P,0.01, ***P,0.001.
doi:10.1371/journal.pone.0039214.g004
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significantly higher than others. No significant change of iNOS
mRNA expression and iNOS activity was found in the wells with
IFN-c alone (Fig. 2A and 2B), but significant increase was found
for NO production at 24 h and 36 h after infection (Fig. 2C).
However, the combination of IFN-c and IL-17A induced
significantly higher levels of iNOS activity and NO production
than IFN-c alone in Cm-infected TC-1 cells at each time point
after infection (Fig. 2B and C). The results suggest that IL-17A can
synergize with IFN-c to enhance IFN-c-mediated iNOS induction
and NO production during Cm infection.
IL-17A Enhances the Inhibitory Activity of IFN-c on Cm
Growth in Pulmonary Epithelial Cells
After showing the synergy of IL-17A and IFN-c in inducing
iNOS activity and NO production in uninfected and Cm-
Figure 5. Inhibition of IL-17A and IFN-c on intracellular Cm growth in cultured ex vivo murine macrophages. Peritoneal macrophages
were collected from BALB/c mice following 4% thioglycollate injection. The macrophage monolayers were then inoculated with Cm for 2 hr followed
by addition of different concentrations of rmIFN-c (10 or 200 ng/ml) and/or rmIL-17A (10 ng/ml or 100 ng/ml). Aminoguanidin (AG) was added to the
wells containing IFN-c and/or IL-17A at a final concentration of 100 mM. Chlamydial inclusions in the macrophage monolayers were stained and
counted and the percentage of inhibition was calculated as described in the Materials and Methods (A). The cells were harvested and RNA was
isolated. The mRNA level of iNOS was measured by RT-PCR. The values of iNOS expression in IFN-c and IL-17A treated cells with or without AG were
normalized to b-actin (B). NO concentration in cell culture supernatant was detected using NO nitrate reductase method (C). The Cm growth (IFU) in
Cm-infected macrophage in absence or presence of AG was assayed (D). The results were presented as the mean 6 SD of triplicate measurements.
*P,0.05. **P,0.01, ***P,0.001.
doi:10.1371/journal.pone.0039214.g005
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led to enhanced inhibition of chlamydial growth. As shown in
Fig. 3A and 3B, IL-17A (10 ng/ml) alone had no effect on
inhibition of Cm growth in TC-1 cells at 36 h after infection,
but it significantly enhanced the inhibitory activity of IFN-c
(20 ng/ml) in a dose-dependent manner. The synergistic
inhibitory effect of IL-17A and IFN-c on chlamydial growth
in TC-1 cells correlated with iNOS induction (Fig. 3C). The
combination of IL-17A with IFN-c induced higher level of
iNOS activity than IFN-c alone in a dose-dependent manner at
36 h after infection. The results indicate that IL-17A can
synergize with IFN-c to inhibit Cm growth, which correlates
with iNOS activity.
IL-17A Synergizes with IFN-c for Inducing iNOS and NO
Production in RAW 264.7 Cells
It is known that one of the main antimicrobial mechanisms of
activated macrophages is the release of NO [18,19]. Using murine
macrophage cell line RAW 264.7, we found that 20 ng/ml IFN-c
alone can induce significant NO production by RAW 264.7 cells,
although no significant change in iNOS mRNA expression was
detected at the measured time point (Fig. 4). However, IL-17A
showed a significantly synergistic effect with IFN-c on iNOS
activity and NO production in murine macrophage cell line RAW
264.7 (Fig. 4 B and C).
IL-17A with IFN-c in an Appropriate Proportion Inhibited
Cm Growth in Cultured ex vivo Macrophages from Mice
In order to test effect on primary cells, we further collected
peritoneal macrophages from naı ¨ve BALB/c mice and tested the
effect of IL-17A alone or in combination with IFN-c on Cm
growth. Isolated peritoneal macrophages were infected in vitro
with Cm. Different concentrations (10 ng/ml or 200 ng/ml) of
IFN-c and/or IL-17A (10 ng/ml or 100 ng/ml) were added to
the culture after inoculation with Cm. The control wells had Cm
infection alone without other treatment. We found that IL-17A
(10 ng/ml or 100 ng/ml) could synergize with high (200 ng/ml),
but not low concentration (10 ng/ml), of IFN-c for inhibiting
intracellular Cm growth in macrophages (Fig. 5–A), In the low
IFN-c (10 ng/ml) concentration, the inhibition rates by both
concentrations of IL-17A (10 ng/ml or 100 ng/ml) with IFN-c
were not significantly higher than IFN-c alone (Fig. 5A). These
results indicated that IL-17A could significantly inhibited Cm
growth in macrophages in higher concentration of IFN-c
(200 ng/ml).
To directly test whether the synergistic inhibitory effect on Cm
growth by IL-17A and IFN-c is dependent on iNOS expression,
we used AG, an analogue of L-arginine that is a potent inhibitor of
iNOS activity, to block the function of iNOS to promote NO
production and the effect on Cm growth. As shown in Fig. 5A,
following cytokines stimulation, the inhibition of Cm growth by
IL-17A and IFN-c in the culture wells with AG was significantly
lower than those wells without AG in different combinations and
concentrations of these cytokines. Consistently, although the
addition of AG had no significant effect on iNOS expression
(Fig. 5B), it significantly lowered NO production (Fig. 5C) and Cm
growth (Fig. 5D). The data indicate that the inhibitory effect on
Cm growth by IL-17A in synergizing with IFN-c is largely
dependent on enhanced iNOS activity and NO production.
TNF-a Synergizes with IFN-c for Enhancing iNOS
Expression and Cm-growth Inhibition in Cm-infected TC-
1 Cells
In order to test whether IL-17A is the only cytokine which can
synergize with IFN-c for iNOS expression and anti-chlamydial
activity, we examined the effect of TNF-a on IFN-c mediated
induction of iNOS expression and Cm-growth inhibition in TC-1
cells. As shown in Fig. 6, compared with IFN-c stimulation alone,
TNF-a (10 ng/ml) and IFN-c (10 ng/ml) combination induced
significantly higher iNOS mRNA expression (Fig. 6A and 6B) at
36 h after Cm infection, in parallel with increased inhibition of
Cm growth (Fig. 6C). The results suggest that not only IL-17A but
also TNF-a, and possibly some other cytokines may synergize with
IFN-c for enhancing iNOS expression and inhibiting Cm growth.
Figure 6. Effect of TNF-a and IFN-c on iNOS gene expression
and Inhibition of intracellular Cm growth in TC-1 cell. Cultured
TC-1 cells were infected with Cm at MOI 2 and treated with rmTNF-
a (10 ng/ml) and/or rmIFN-c (10 ng/ml) at 2 h postinfection. The cells
were harvested at 36 h after infection and RNAs were isolated. The
mRNA level of iNOS was measured by RT-PCR (A). The values of iNOS
expression were normalized to b-actin. The results were presented as
the mean 6 SD of triplicate measurements (B). Cm was isolated from
infected TC-1 cells at 36 h after infection and Cm was quantified as
IFUs/ml. The percentage of inhibition was calculated as described in the
Materials and Methods(C). *P,0.05, ***P,0.001.
doi:10.1371/journal.pone.0039214.g006
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on iNOS Expression
Our previous study has shown that IL-17A-neutralized mice led
to more serious disease and in vivo chlamydial growth [14]. To
test whether the neutralization of IL-17A has effect on iNOS
expression in the lung, we further compared the expression of
iNOS between IL-17A-neutralized mice and isotype control
(IgG2a)-treated mice after Cm lung infection. As shown in
Figure 7 A&B, IL-17A-neutralized mice exhibited significantly
greater body weight loss and higher bacterial loads in the lung
than IgG2a-treated mice at both day7 and day 13 following
infection. Consistently, a significant reduction of iNOS expression
in the IL-17A-neutralized mice was observed in comparison with
IgG2a-treated mice at day 7 after infection (Fig. 7C and 7D),
which further suggests that the inhibitory role of IL-17A on Cm
growth involves enhancing iNOS expression.
Discussion
iNOS-derived NO, as a potent antimicrobial agent, exerts
profound cytotoxic effects on intracellular pathogens such as
Mycobacteria, Leishmania, Plasmodium, Toxoplasma and Chlamydia
[20,21]. The present study has demonstrated a significant
synergistic effect of IL-17A on IFNc-mediated enhancement of
iNOS expression and NO production, and inhibition of chlamyd-
ial growth in mouse lung epithelial and macrophage cells. We
found that IL-17A significantly enhanced IFN-c mediated increase
of iNOS activity and NO production in mouse epithelial and
macrophage cell lines and primary peritoneal macrophages in Cm
infected cells, which was associated with enhanced inhibition of
chlamydial growth. In addition, adding of AG (a potent inhibitor
of iNOS) into the system significantly restored Cm growth.
Further, neutralization of IL-17A in vivo reduced iNOS expres-
sion following Cm lung infection, which was associated with
increased chlamydial growth in the lung.
It has been reported that protective Chlamydia-specific T-cell
lines and clones can interact with infected epithelial cells to inhibit
the growth of chlamydiae in an in vitro model, polarized epithelial-
lymphocyte co-culture (PELC) system [1]. It was found in that
study that the inhibition mainly correlated with high levels of IFN-
c secretion and NO production because neutralizing anti-IFN-c
antibodies and the NO synthase inhibitor largely reversed the
inhibition [1]. Pulmonary epithelial cells are the principal target
cells of chlamydial infection. After intranasal infection with Cm,
cytokines such as IFN-c, TNF-a and IL-17A can directly interact
with pulmonary epithelial cells to inhibit intracellular Cm growth
through inducing NO production. In the present study, we found
that IL-17A have the ability to augment IFN-c-mediated
induction of iNOS expression in Cm-infected pulmonary epithelial
cells and inhibition of Cm growth. Previous studies have shown
Figure 7. The comparison of iNOS expression between IL-17A-neutralized mice and IgG2a-treated control mice. Mice were intranasally
infected with 1610
3 IFUs of Cm. For neutralization of airway IL-17A, mice were intranasally administered with 10 mg of anti-mouse IL-17A mAb in
40 ml of PBS at 2 h post-infection (p.i.), followed by subsequent administration of the same dose of Ab at 48-h intervals. Infected control mice were
administered intranasally with anti-murine IL-17A Ab isotype control (IgG2a) in the same schedule as anti-IL-17A delivery. Mice were monitored for
body weight changes (A) and killed at day 7 after infection. The lungs were collected and analyzed for in vivo chlamydial growth (B) and gene
expression (C and D) as described in Materials and Methods. D, densitometric analysis of iNOS mRNA RT-PCR products from lung in mice at day 7
postinfection. Values were normalized to b-actin and expressed as the mean 6 SD with n=5 for each point. **, p,0.01.
doi:10.1371/journal.pone.0039214.g007
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be controlled by various agonists, such as TNF-a, IL-8, IL-1b and
LPS, especially in combination with IFN-c, in both mice and
human [22–24]. Combination of IL-8 and IFNc induces iNOS
mRNA expression and functional enzyme production in cultured
human keratinocytes [22]. Synergism of TNF-a and IFN-c in
inhibition of C. pneumoniae replication in vitro and in vivo was also
reported [23]. Notably, LPS was also found to enhance iNOS
expression in synergy with IFN-c [24]. Since LPS is a common
contaminant in recombinant proteins, the possible non-specific
influence of LPS could be a concern in this type of study.
However, the synergistic effect observed in the present study is
unlikely due to contaminated LPS in the IL-17A preparation
because the LPS level in the IL-17A is less than 0.1 ng per 1 mgo f
the cytokine, much lower than that used in the study showing the
effect of LPS [24].
It was reported that IFN-c mediated inhibition of Chlamydia
trachomatis replication was mainly through inducing nitrite pro-
duction in the murine macrophage cell line, RAW 264.7 [25]. In
mouse peritoneal macrophages treated with IFN-c, L-NMMA (an
inhibitor of iNOS) inhibited nitrite production and partly restored
Cm replication [25]. Murine macrophages have been reported to
synthesize the obligatory cofactor tetrahydrobiopterin (BH4),
essential for stabilization and function of the iNOS enzyme
protein [26], although this has not been confirmed in human
macrophages so far [27]. In the present study, we found IL-17A
synergizes with IFN-c in iNOS expression and NO production in
macrophages. Consistently, we found that IL-17A synergizes with
IFN-c for inhibition of Cm growth in mouse peritoneal
macrophages, which was significantly weakened by adding AG,
an inhibitor of iNOS activity. Therefore, IL-17A synergizing with
IFN-c mediated NO production in macrophages is another
important mechanism for inhibition of Cm replication.
Besides anti-microbial function, NO also acts as a regulator of
the immune response, mainly by suppressing T cell activaty and
function [9,28]. Higher NO release by macrophage is known to
induce immunosuppression and down-regulate Th1 cell develop-
ment by inhibition of macrophage IL-12 synthesis and selective
induction of apoptosis of activated Th1 cells [8,19]. However, an
overproduction of NO might cause abnormal inflammation and
cellular damage [16,28], which may augment the susceptibility of
host against Chlamydia infection. It has been proposed that the
quantity of NO released by infected macrophages is critical for
balancing pathogenic and protective responses against chlamydial
infection [19]. In the present study, we found that the inhibition
rate of Cm growth was not increased by increasing the
concentration of IL-17A when the cells were treated with
200 ng/ml IFN-c (Fig. 5), suggesting that excessive production
of IL-17A may not be helpful for controlling Cm infection.
Therefore, an appropriate level of IL-17A production is important
for host defense against chlamydial infection.
The demonstration of the synergy of IL-17A and IFN-c in
inhibiting chlamydial growth may have implication in rational
vaccine development. Efforts have been made to enhance Th1
response in chlamydial infection by vaccination. The present data
suggest that the combinational enhancement of both Th1 and
Th17 responses may be a more efficient way to enhance host
defense against chlamydial infections. However, it should be noted
that some of the functions of IL-17A observed in mouse studies
have yet to be confirmed in humans. Specifically, the role of IL-
17A in human lung chlamydial infection remains unclear.
Moreover, considering the potential toxic effect of NO, the
significance of IL-17A-mediated NO production and its correla-
tion with chlamydial inhibition should not be overemphasized.
Therefore, it is important to further explore these issues in humans
in the future. Notably, a T cell which produce both IL-17A and
IFN-c has been reported recently [29,30]. Therefore, it seem
reasonable to predict that this type of cells could be more efficient
for the cooperation of IL-17A and IFN-c than the different Th1
and Th17 cells for the inhibition of chlamydial growth. However,
the possibility needs to be experimentally tested.
In conclusion, our study demonstrated that IL-17A can
synergize with IFN-c to inhibit intracellular Cm growth through
enhancing intracellular iNOS expression. The finding provides
new insight into the mechanism of the protective role played by
IL-17A during intracellular pathogen infection, particularly
Chlamydia. However, further studies are needed for using IL-17A
as an immune adjuvant in chlamydial vaccination.
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